A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature
about
A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study to Assess the Efficacy ...... h a BRCAness Genomic Signature
@en
A Study to Assess the Efficacy ...... h a BRCAness Genomic Signature
@nl
type
label
A Study to Assess the Efficacy ...... h a BRCAness Genomic Signature
@en
A Study to Assess the Efficacy ...... h a BRCAness Genomic Signature
@nl
prefLabel
A Study to Assess the Efficacy ...... h a BRCAness Genomic Signature
@en
A Study to Assess the Efficacy ...... h a BRCAness Genomic Signature
@nl
P1476
A Single Arm, Open-label, Phas ...... h a BRCAness Genomic Signature
@en
P17
P1813
RUBY
@en
P3098
NCT02505048
P4844
P580
2016-03-01T00:00:00Z
P582
2019-02-01T00:00:00Z